Retour

Atossa Therapeutics Announces Support of New Breast Cancer Screening Guidelines

News Product / Services Announcement

SEATTLE, May 07, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced its support of new guidelines released by the U.S. Preventive Services Task Force (USPSTF) recommending that women begin breast cancer screening starting at age 40. Atossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer.

GlobeNewswire Inc. • 07/05/2024 à 14:30:00
Atossa Therapeutics, Inc. Common Stock
Address: 107 SPRING STREET
Postal Code: 98104
City: SEATTLE
State: WA
Phone Number: 206.588.0256
Website: https://www.atossatherapeutics.com
Status: Active
Company Info

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

List Date2012-11-08
MarketStocks
LocalUS
Primary ExchangeXNAS
TypeCS
Currency NameUSD
CIK0001488039
Composite figiBBG002NCD8C8
Share Class figiBBG002NCD954
Market Cap197,439,143 USD
SIC Code2834
SIC DescriptionPHARMACEUTICAL PREPARATIONS
Total Employees10
Share Class Shares Outstanding125760000
Weighted Shares Outstanding125757416
Round Lot100
Updated date2024-05-19
Stats
Last 5 days
17-05
16-05
15-05
14-05
13-05
Last
1.564
1.634
1.615
1.56
1.37
Variance
-2.68%
1.18%
4.87%
14.12%
-3.52%
Open
1.607
1.615
1.54
1.367
1.42
Highest
1.625
1.655
1.69
1.589
1.549
Lowest
1.615
1.655
1.68
1.571
1.52
History
PeriodVarhighestlowest
1 week
10.14%
1.549
1.52
1 month
11.08%
1.455
1.455
3 month
51.4%
1.033
0.976
6 month
130.78%
0.74
0.6702
1 year
120.28%
0.73
0.62
3 year
-49.39%
3.29
0.5
5 year
-37.44%
2.582
0.5
10 year
-99.28%
225
0.5
Stock Financials
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-15 2023-08-14 2023-11-13 UNPUB
Assets 116,200,000 108,355,000 101,695,000 UNPUB
Current Assets 110,869,000 106,003,000 97,648,000 UNPUB
Current Liabilities 2,944,000 3,478,000 3,444,000 UNPUB
Equity 113,256,000 104,877,000 98,251,000 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 113,256,000 104,877,000 98,251,000 UNPUB
Liabilities 2,944,000 3,478,000 3,444,000 UNPUB
Liabilities And Equity 116,200,000 108,355,000 101,695,000 UNPUB
Noncurrent Assets 5,331,000 2,352,000 4,047,000 UNPUB
Noncurrent Liabilities 0 0 0 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-15 2023-08-14 2023-11-13 UNPUB
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -7,022,000 7,022,000 -16,859,000 UNPUB
Net Cash Flow, Continuing -7,022,000 7,022,000 -16,859,000 UNPUB
Net Cash Flow From Financing Activities 0 11,500,000 -12,975,000 UNPUB
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB -12,975,000 UNPUB
Net Cash Flow From Investing Activities 0 -13,000 -1,000 UNPUB
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB -1,000 UNPUB
Net Cash Flow From Operating Activities -7,022,000 -4,465,000 -3,883,000 UNPUB
Net Cash Flow From Operating Activities, Continuing -7,022,000 -4,465,000 -3,883,000 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-15 2023-08-14 2023-11-13 UNPUB
Comprehensive Income/Loss -6,281,000 -9,830,000 -6,229,000 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent -6,281,000 -9,830,000 -6,229,000 UNPUB
Other Comprehensive Income/Loss 0 0 -6,229,000 UNPUB
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-15 2023-08-14 2023-11-13 UNPUB
Basic Earnings Per Share 0 0 0 UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -6,281,000 -9,830,000 -6,229,000 UNPUB
Income/Loss From Continuing Operations Before Tax -6,281,000 -9,830,000 -6,229,000 UNPUB
Income Tax Expense/Benefit 0 0 0 UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -6,281,000 -9,830,000 -6,229,000 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent -6,281,000 -9,830,000 -6,229,000 UNPUB
Net Income/Loss Available To Common Stockholders, Basic -6,281,000 -9,830,000 -6,229,000 UNPUB
Operating Expenses 7,098,000 7,793,000 7,468,000 UNPUB
Operating Income/Loss -7,098,000 -7,793,000 -7,468,000 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 0 UNPUB
Revenues 0 0 0 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-09 2022-08-08 2022-11-07 2023-03-22
Assets 137,478,000 134,048,000 126,724,000 123,532,000
Current Assets 136,848,000 133,421,000 123,395,000 118,197,000
Current Liabilities 2,322,000 3,792,000 2,868,000 5,568,000
Equity 135,156,000 130,255,000 123,856,000 117,964,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 135,156,000 130,255,000 123,856,000 117,964,000
Liabilities 2,322,000 3,792,000 2,868,000 5,568,000
Liabilities And Equity 137,478,000 134,048,000 126,724,000 123,532,000
Noncurrent Assets 630,000 627,000 3,329,000 5,335,000
Noncurrent Liabilities 0 0 0 0
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-09 2022-08-08 2022-11-07 2023-03-22
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 0 0 0
Net Cash Flow, Continuing 0 0 0 0
Net Cash Flow From Financing Activities 4,891,000 5,949,000 8,116,000 25,487,000
Net Cash Flow From Financing Activities, Continuing 4,891,000 5,949,000 8,116,000 25,487,000
Net Cash Flow From Investing Activities -13,000 0 -2,706,000 -4,727,000
Net Cash Flow From Investing Activities, Continuing -13,000 0 -2,706,000 -4,727,000
Net Cash Flow From Operating Activities -4,878,000 -5,949,000 -5,410,000 -20,760,000
Net Cash Flow From Operating Activities, Continuing -4,878,000 -5,949,000 -5,410,000 -20,760,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-09 2022-08-08 2022-11-07 2023-03-22
Comprehensive Income/Loss -4,786,000 -6,672,000 -8,065,000 -26,960,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -4,786,000 -6,672,000 -8,065,000 -26,960,000
Other Comprehensive Income/Loss 0 0 -8,065,000 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB -54,000 UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-09 2022-08-08 2022-11-07 2023-03-22
Basic Earnings Per Share 0 0 0 0
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -4,786,000 -6,672,000 -8,011,000 -26,960,000
Income/Loss From Continuing Operations Before Tax -4,786,000 -6,672,000 -8,011,000 -26,960,000
Income Tax Expense/Benefit 0 0 0 0
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -4,786,000 -6,672,000 -8,011,000 -26,960,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -4,786,000 -6,672,000 -8,011,000 -26,960,000
Net Income/Loss Available To Common Stockholders, Basic -4,786,000 -6,672,000 -8,011,000 -26,960,000
Operating Expenses 4,747,000 6,595,000 8,205,000 27,691,000
Operating Income/Loss -4,747,000 -6,595,000 -8,205,000 -27,691,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-14 2021-08-13 2021-11-15 2022-02-28
Assets 141,080,546 145,868,005 143,023,647 141,262,000
Current Assets 141,031,313 145,830,918 142,986,884 141,240,000
Current Liabilities 1,379,147 1,796,103 1,675,821 3,126,000
Equity 139,701,399 144,071,902 141,347,826 138,136,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 139,701,399 144,071,902 141,347,826 138,136,000
Liabilities -139,701,399 -144,071,902 1,675,821 3,126,000
Liabilities And Equity 141,080,546 145,868,005 143,023,647 141,262,000
Noncurrent Assets 49,233 37,087 36,763 22,000
Noncurrent Liabilities 0 0 0 0
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-14 2021-08-13 2021-11-15 2022-02-28
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 0 100,487,284 96,823,000
Net Cash Flow, Continuing 0 0 100,487,284 96,823,000
Net Cash Flow From Financing Activities 102,428,710 10,195,641 678,931 113,304,000
Net Cash Flow From Financing Activities, Continuing 102,428,710 10,195,641 678,931 113,304,000
Net Cash Flow From Investing Activities -98,019,922 -4,859,429 102,869,955 -9,000
Net Cash Flow From Investing Activities, Continuing -98,019,922 -4,859,429 102,869,955 -9,000
Net Cash Flow From Operating Activities -4,408,788 -5,336,212 -3,061,602 -16,472,000
Net Cash Flow From Operating Activities, Continuing -4,408,788 -5,336,212 -3,061,602 -16,472,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-14 2021-08-13 2021-11-15 2022-02-28
Comprehensive Income/Loss -3,538,069 -7,039,248 -5,197,145 -20,606,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -3,538,069 -7,039,248 -5,197,145 -20,606,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-14 2021-08-13 2021-11-15 2022-02-28
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -3,538,069 -7,039,248 -5,197,145 -20,606,000
Income/Loss From Continuing Operations Before Tax -3,538,069 -7,039,248 -5,197,145 -20,606,000
Income Tax Expense/Benefit 0 0 0 0
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -3,538,069 -7,039,248 -5,197,145 -20,606,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -3,538,069 -7,039,248 -5,197,145 -20,606,000
Net Income/Loss Available To Common Stockholders, Basic -3,538,069 -7,039,248 -5,197,145 -20,606,000
Operating Expenses 3,530,728 7,003,766 5,158,594 20,521,000
Operating Income/Loss -3,530,728 -7,003,766 -5,158,594 -20,521,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-13 2020-08-13 2020-11-13 2021-03-31
Assets 11,812,302 10,205,699 11,437,660 42,839,453
Current Assets 11,667,120 10,061,681 11,318,317 42,770,175
Current Liabilities 907,952 1,826,673 1,565,366 15,671,521
Equity 10,896,337 8,374,306 9,871,077 27,167,932
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 10,896,337 8,374,306 9,871,077 27,167,932
Liabilities 915,965 1,831,393 1,566,583 15,671,521
Liabilities And Equity 11,812,302 10,205,699 11,437,660 42,839,453
Noncurrent Assets 145,182 144,018 119,343 69,278
Noncurrent Liabilities 0 0 1,217 0
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-13 2020-08-13 2020-11-13 2021-03-31
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -3,229,995 -1,888,405 1,643,214 26,972,535
Net Cash Flow, Continuing -3,229,995 -1,888,405 1,643,214 26,972,535
Net Cash Flow From Financing Activities UNPUB UNPUB 4,324,249 38,552,184
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB 4,324,249 38,552,184
Net Cash Flow From Investing Activities UNPUB UNPUB -2,757 -9,367
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB -2,757 -9,367
Net Cash Flow From Operating Activities -3,229,995 -2,229,422 -2,678,278 -11,570,282
Net Cash Flow From Operating Activities, Continuing -3,229,995 -2,229,422 -2,678,278 -11,570,282
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-13 2020-08-13 2020-11-13 2021-03-31
Comprehensive Income/Loss -2,947,420 -3,906,142 -3,491,071 -17,827,952
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -2,947,420 -3,906,142 -3,491,071 -17,827,952
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-13 2020-08-13 2020-11-13 2021-03-31
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -2,947,420 -3,906,142 -3,491,071 -17,827,952
Income/Loss From Continuing Operations Before Tax -2,947,420 -3,906,142 -3,491,071 -17,827,952
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 0
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -2,947,420 -3,906,142 -3,491,071 -17,827,952
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -2,947,420 -3,906,142 -3,491,071 -17,827,952
Net Income/Loss Available To Common Stockholders, Basic -2,947,420 -3,906,142 -3,491,071 -22,330,751
Operating Expenses 2,937,009 3,935,807 3,508,816 14,607,392
Operating Income/Loss -2,937,009 -3,935,807 -3,508,816 -14,607,392
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 4,502,799
Preferred Stock Dividends And Other Adjustments 0 0 0 4,502,799
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-13 2019-08-13 2019-11-13 2020-03-26
Assets 21,024,728 18,609,313 16,596,523 14,489,855
Current Assets 20,779,528 18,388,141 16,400,629 14,319,266
Current Liabilities 1,491,141 1,032,829 1,564,310 1,322,742
Equity 19,496,190 17,552,457 15,018,195 13,156,005
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 19,496,190 17,552,457 15,018,195 13,156,005
Liabilities 1,528,538 1,056,856 1,578,328 1,333,850
Liabilities And Equity 21,024,728 18,609,313 16,596,523 14,489,855
Noncurrent Assets 245,200 221,172 195,894 170,589
Noncurrent Liabilities 0 0 14,018 11,108
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-13 2019-08-13 2019-11-13 2020-03-26
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 6,678,034 -1,768,984 2,200,643
Net Cash Flow, Continuing 0 6,678,034 -1,768,984 2,200,643
Net Cash Flow From Financing Activities 11,336,710 0 0 11,336,710
Net Cash Flow From Financing Activities, Continuing 11,336,710 0 0 11,336,710
Net Cash Flow From Investing Activities -9,187,754 9,180,129 0 -7,625
Net Cash Flow From Investing Activities, Continuing -9,187,754 9,180,129 0 -7,625
Net Cash Flow From Operating Activities -2,148,956 -2,502,095 -1,768,984 -9,128,442
Net Cash Flow From Operating Activities, Continuing -2,148,956 -2,502,095 -1,768,984 -9,128,442
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-13 2019-08-13 2019-11-13 2020-03-26
Comprehensive Income/Loss -4,073,307 -7,262,529 -3,285,914 -17,239,777
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -4,073,307 -7,262,529 -3,285,914 -17,239,777
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-13 2019-08-13 2019-11-13 2020-03-26
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -4,073,307 -7,262,529 -3,285,914 -17,239,777
Income/Loss From Continuing Operations Before Tax -4,073,307 -7,262,529 -3,285,914 -17,239,777
Income Tax Expense/Benefit 0 UNPUB UNPUB 0
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -4,073,307 -7,262,529 -3,285,914 -17,239,777
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -4,073,307 -7,262,529 -3,285,914 -17,239,777
Net Income/Loss Available To Common Stockholders, Basic -4,073,307 -7,262,529 -3,285,914 -17,239,777
Operating Expenses 4,064,329 7,286,069 3,298,198 17,265,425
Operating Income/Loss -4,064,329 -7,286,069 -3,298,198 -17,265,425
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-14 2018-08-13 2018-11-14 2019-03-28
Assets 5,980,302 16,577,846 14,124,372 11,720,446
Current Assets 5,735,374 16,408,171 13,922,943 11,549,366
Current Liabilities 720,710 3,011,081 3,555,263 2,915,436
Equity 5,259,592 13,566,765 10,569,109 8,805,010
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 5,259,592 13,566,765 10,569,109 8,805,010
Liabilities 720,710 3,011,081 3,555,263 2,915,436
Liabilities And Equity 5,980,302 16,577,846 14,124,372 11,720,446
Noncurrent Assets 244,928 169,675 201,429 171,080
Noncurrent Liabilities 0 0 0 0
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-14 2018-08-13 2018-11-14 2019-03-28
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 0 8,019,267 -2,301,149 3,218,024
Net Cash Flow, Continuing 0 8,019,267 -2,301,149 3,218,024
Net Cash Flow From Financing Activities 2,437,950 9,852,601 0 12,290,551
Net Cash Flow From Financing Activities, Continuing 2,437,950 9,852,601 0 12,290,551
Net Cash Flow From Investing Activities -51,068 -423 -2,957 -110,906
Net Cash Flow From Investing Activities, Continuing -51,068 -423 -2,957 -110,906
Net Cash Flow From Operating Activities -2,386,882 -1,832,911 -2,298,192 -8,961,621
Net Cash Flow From Operating Activities, Continuing -2,386,882 -1,832,911 -2,298,192 -8,961,621
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-14 2018-08-13 2018-11-14 2019-03-28
Comprehensive Income/Loss -1,874,382 -15,621,885 -3,309,866 -11,404,934
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -1,874,382 -15,621,885 -3,309,866 -11,404,934
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-14 2018-08-13 2018-11-14 2019-03-28
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -1,874,382 -15,621,885 -3,309,866 -11,404,934
Income/Loss From Continuing Operations Before Tax -1,874,382 -4,142,577 -3,309,866 -11,404,934
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 0
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -1,874,382 -15,621,885 -3,309,866 -11,404,934
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -1,874,382 -4,142,577 -3,309,866 -11,404,934
Net Income/Loss Available To Common Stockholders, Basic -1,874,382 -15,621,885 -3,309,866 -22,884,242
Operating Expenses 1,874,441 4,142,656 3,309,970 11,434,233
Operating Income/Loss -1,874,441 -4,142,656 -3,309,970 -11,434,233
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 11,479,308
Preferred Stock Dividends And Other Adjustments 0 0 0 11,479,308
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-11 2017-08-14 2017-11-13 2018-03-08
Assets 2,303,182 4,709,378 3,634,621 8,164,094
Current Assets 1,516,842 3,976,129 2,950,109 7,898,034
Current Liabilities 774,777 1,905,776 1,071,823 1,225,407
Equity 1,528,405 2,803,602 2,562,798 6,938,687
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 1,528,405 2,803,602 2,562,798 6,938,687
Liabilities 774,777 1,905,776 1,071,823 1,225,407
Liabilities And Equity 2,303,182 4,709,378 3,634,621 8,164,094
Noncurrent Assets 786,340 733,249 684,512 266,060
Noncurrent Liabilities 0 0 0 0
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-11 2017-08-14 2017-11-13 2018-03-08
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -1,860,951 2,523,012 -956,360 4,189,507
Net Cash Flow, Continuing -1,860,951 2,523,012 -956,360 4,189,507
Net Cash Flow From Financing Activities UNPUB UNPUB 745,333 10,783,457
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB 745,333 10,783,457
Net Cash Flow From Investing Activities UNPUB UNPUB UNPUB UNPUB
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB UNPUB UNPUB
Net Cash Flow From Operating Activities 1,900,000 1,300,000 -8,111,268 -6,593,950
Net Cash Flow From Operating Activities, Continuing -1,860,951 -1,348,624 -1,701,693 -6,593,950
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-11 2017-08-14 2017-11-13 2018-03-08
Comprehensive Income/Loss -1,703,554 -2,241,489 -2,184,510 -8,122,581
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -1,703,554 -2,241,489 -2,184,510 -8,122,581
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-11 2017-08-14 2017-11-13 2018-03-08
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -1,703,554 -2,241,489 -2,184,510 -8,122,581
Income/Loss From Continuing Operations Before Tax -1,703,554 -2,241,489 -2,184,510 -8,122,581
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -1,703,554 -2,241,489 -2,184,510 -8,122,581
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -1,703,554 -2,241,489 -2,184,510 -8,122,581
Net Income/Loss Available To Common Stockholders, Basic -1,703,554 -4,809,621 -2,184,510 -10,690,713
Operating Expenses 1,686,846 1,896,263 2,055,927 7,649,171
Operating Income/Loss -1,686,846 -1,896,263 -2,055,927 -7,649,171
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 2,568,132 0 2,568,132
Preferred Stock Dividends And Other Adjustments 0 2,568,132 0 2,568,132
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-05 2016-08-12 2016-11-14 2017-03-16
Assets 5,100,021 3,284,619 6,278,241 4,144,372
Current Assets 3,385,593 1,454,995 4,563,928 3,254,563
Current Liabilities 1,326,835 874,265 863,767 1,047,266
Equity 3,773,186 2,410,354 5,414,474 3,097,106
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 3,773,186 2,410,354 5,414,474 3,097,106
Liabilities 1,326,835 874,265 863,767 1,047,266
Liabilities And Equity 5,100,021 3,284,619 6,278,241 4,144,372
Noncurrent Assets 1,714,428 1,829,624 1,714,313 889,809
Noncurrent Liabilities 0 0 0 0
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-05 2016-08-12 2016-11-14 2017-03-16
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -833,238 -1,691,791 3,197,311 -687,933
Net Cash Flow, Continuing -833,238 -1,691,791 3,197,311 -687,933
Net Cash Flow From Financing Activities 2,166,537 -32,563 2,561,895 4,695,869
Net Cash Flow From Financing Activities, Continuing 2,166,537 -32,563 2,561,895 4,695,869
Net Cash Flow From Investing Activities -5,020 79 -82 -9,213
Net Cash Flow From Investing Activities, Continuing -5,020 79 -82 -9,213
Net Cash Flow From Operating Activities -2,994,755 -1,659,307 635,498 -5,374,589
Net Cash Flow From Operating Activities, Continuing -2,994,755 -1,659,307 635,498 -5,374,589
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-05 2016-08-12 2016-11-14 2017-03-16
Comprehensive Income/Loss -2,327,540 -1,722,383 204,689 -6,368,885
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -2,327,540 -1,722,383 204,689 -6,368,885
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-05 2016-08-12 2016-11-14 2017-03-16
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue 0 0 UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit 0 0 UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -2,327,540 -1,722,383 204,689 -6,368,885
Income/Loss From Continuing Operations Before Tax -2,327,540 -1,722,383 204,689 -6,368,885
Income Tax Expense/Benefit 0 0 0 UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -2,327,540 -1,722,383 204,689 -6,368,885
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -2,327,540 -1,722,383 204,689 -6,368,885
Net Income/Loss Available To Common Stockholders, Basic -2,327,540 -1,722,383 204,689 -6,368,885
Operating Expenses 2,327,540 1,722,383 1,558,435 7,968,590
Operating Income/Loss -2,327,540 -1,722,383 -1,558,435 -7,968,590
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 0 0 0 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-13 2015-08-06 2015-11-12 2016-03-30
Assets 13,802,865 16,561,200 12,357,390 6,243,321
Current Assets 11,366,969 13,755,519 9,542,010 4,294,851
Current Liabilities 3,486,556 3,413,663 3,292,605 2,501,587
Equity 10,283,852 13,124,987 9,059,097 3,741,734
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 10,283,852 13,124,987 9,059,097 3,741,734
Liabilities 3,519,013 3,436,213 3,298,293 2,501,587
Liabilities And Equity 13,802,865 16,561,200 12,357,390 6,243,321
Noncurrent Assets 2,435,896 2,805,681 2,815,380 1,948,470
Noncurrent Liabilities 32,457 22,550 5,688 0
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-13 2015-08-06 2015-11-12 2016-03-30
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 1,227,651 1,674,566 -3,563,496 -4,784,823
Net Cash Flow, Continuing 1,227,651 1,674,566 -3,563,496 -1,993,196
Net Cash Flow From Financing Activities 4,292,349 5,210,849 -53,856 9,456,892
Net Cash Flow From Financing Activities, Continuing 4,292,349 5,210,849 -53,856 9,456,892
Net Cash Flow From Investing Activities -66,035 -15,630 -29,084 -288,419
Net Cash Flow From Investing Activities, Continuing -66,035 -15,630 -29,084 -130,735
Net Cash Flow From Operating Activities -2,998,663 -3,520,653 -3,480,556 -13,953,296
Net Cash Flow From Operating Activities, Continuing -2,998,663 -3,520,653 -3,480,556 -11,319,353
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-13 2015-08-06 2015-11-12 2016-03-30
Comprehensive Income/Loss -3,335,291 -3,145,326 -4,318,111 -15,760,323
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -3,335,291 -3,145,326 -4,318,111 -15,760,323
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-13 2015-08-06 2015-11-12 2016-03-30
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 5,208,559 5,839,483 5,090,355 12,759,945
Cost Of Revenue 1,207,954 1,854,711 313,406 132,411
Costs And Expenses 5,208,559 5,839,483 5,090,355 12,759,945
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit 665,314 839,446 458,838 -130,653
Income/Loss From Continuing Operations After Tax -3,335,291 -3,145,326 -4,318,111 -12,758,187
Income/Loss From Continuing Operations Before Tax -3,335,291 -3,145,326 -4,318,111 -12,758,187
Income Tax Expense/Benefit 0 0 0 0
Interest Expense, Operating 1,784 UNPUB UNPUB UNPUB
Net Income/Loss -3,335,291 -3,145,326 -4,318,111 -15,760,323
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -3,335,291 -3,145,326 -4,318,111 -15,760,323
Net Income/Loss Available To Common Stockholders, Basic -3,335,291 -3,145,326 -4,318,111 -15,760,323
Operating Expenses 3,949,190 4,033,391 4,846,294 12,627,965
Operating Income/Loss -3,283,876 -3,193,945 -4,387,456 -12,758,618
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 1,873,268 2,694,157 772,244 1,758
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2014-05-14 2014-08-12 2014-11-12 2015-03-30
Assets 22,383,091 19,819,098 16,772,226 11,764,002
Current Assets 17,700,133 14,673,902 11,715,995 9,085,671
Current Liabilities 1,082,045 1,563,494 1,539,617 2,214,176
Equity 21,301,046 18,255,604 15,232,609 9,498,127
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 21,301,046 18,255,604 15,232,609 9,498,127
Liabilities 1,082,045 1,563,494 1,539,617 2,265,875
Liabilities And Equity 22,383,091 19,819,098 16,772,226 11,764,002
Noncurrent Assets 4,682,958 5,145,196 5,056,231 2,678,331
Noncurrent Liabilities 0 0 0 51,699
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2014-05-14 2014-08-12 2014-11-12 2015-03-30
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 10,248,790 -2,292,460 -2,924,240 2,158,557
Net Cash Flow, Continuing 10,248,790 -2,292,460 -2,924,240 2,158,557
Net Cash Flow From Financing Activities 12,955,745 50,000 150,000 13,057,264
Net Cash Flow From Financing Activities, Continuing 12,955,745 50,000 150,000 13,057,264
Net Cash Flow From Investing Activities -102,966 -88,104 -96,439 -343,257
Net Cash Flow From Investing Activities, Continuing -102,966 -88,104 -96,439 -343,257
Net Cash Flow From Operating Activities -2,603,989 -2,254,356 -2,977,801 -10,555,450
Net Cash Flow From Operating Activities, Continuing -2,603,989 -2,254,356 -2,977,801 -10,555,450
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2014-05-14 2014-08-12 2014-11-12 2015-03-30
Comprehensive Income/Loss -2,411,531 -3,187,976 -3,245,395 -14,657,926
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -2,411,531 -3,187,976 -3,245,395 -14,657,926
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2014-05-14 2014-08-12 2014-11-12 2015-03-30
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 2,435,655 3,197,851 3,248,821 15,183,880
Cost Of Revenue 0 0 0 340,658
Costs And Expenses 2,435,655 3,197,851 3,248,821 15,183,880
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit 24,124 9,875 3,426 185,296
Income/Loss From Continuing Operations After Tax -2,411,531 -3,187,976 -3,245,395 -14,657,926
Income/Loss From Continuing Operations Before Tax -2,411,531 -3,187,976 -3,245,395 -14,657,926
Income Tax Expense/Benefit 0 0 0 0
Interest Expense, Operating 749 1,443 151 15,769
Net Income/Loss -2,411,531 -3,187,976 -3,245,395 -14,657,926
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -2,411,531 -3,187,976 -3,245,395 -14,657,926
Net Income/Loss Available To Common Stockholders, Basic -2,411,531 -3,187,976 -3,245,395 -14,657,926
Operating Expenses 2,435,049 3,196,408 3,248,681 14,827,713
Operating Income/Loss -2,410,925 -3,186,533 -3,245,255 -14,642,417
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 24,124 9,875 3,426 525,954
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2013-05-15 2013-08-14 2013-11-12 2014-03-27
Assets 8,911,829 10,055,002 13,482,221 12,009,047
Current Assets 4,165,636 5,355,137 8,595,445 7,413,821
Current Liabilities 1,936,265 1,774,170 1,942,272 1,407,396
Equity 6,975,564 8,280,832 11,539,949 10,601,651
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 6,975,564 8,280,832 11,539,949 10,601,651
Liabilities 1,936,265 1,774,170 1,942,272 1,407,396
Liabilities And Equity 8,911,829 10,055,002 13,482,221 12,009,047
Noncurrent Assets 4,746,193 4,699,865 4,886,776 4,595,226
Noncurrent Liabilities 0 0 0 0
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2013-05-15 2013-08-14 2013-11-12 2014-03-27
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -339,998 1,054,313 5,254,048 4,616,964
Net Cash Flow, Continuing -339,998 1,054,313 5,254,048 4,616,964
Net Cash Flow From Financing Activities 1,003,314 3,244,961 8,302,822 13,936,823
Net Cash Flow From Financing Activities, Continuing 1,003,314 3,244,961 8,302,822 13,936,823
Net Cash Flow From Investing Activities -8,500 -81,370 -310,804 -489,815
Net Cash Flow From Investing Activities, Continuing -8,500 -81,370 -310,804 -489,815
Net Cash Flow From Operating Activities -1,334,812 -2,109,278 -2,737,970 -8,830,044
Net Cash Flow From Operating Activities, Continuing -1,334,812 -2,109,278 -2,737,970 -8,830,044
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2013-05-15 2013-08-14 2013-11-12 2014-03-27
Comprehensive Income/Loss -1,941,440 -2,583,699 -3,501,845 -10,784,708
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -1,941,440 -2,583,699 -3,501,845 -10,784,708
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2013-05-15 2013-08-14 2013-11-12 2014-03-27
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses 2,124,110 2,909,777 3,578,442 11,417,266
Cost Of Revenue 66,464 222,160 25,938 345,519
Costs And Expenses 2,124,110 2,909,777 3,578,442 11,417,266
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit 116,206 103,918 50,659 137,093
Income/Loss From Continuing Operations After Tax -1,941,440 -2,583,699 -3,501,845 -10,784,708
Income/Loss From Continuing Operations Before Tax -1,941,440 -2,583,699 -3,501,845 -10,784,708
Income Tax Expense/Benefit 0 0 0 0
Interest Expense, Operating 7 352 1 360
Net Income/Loss -1,941,440 -2,583,699 -3,501,845 -10,784,708
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -1,941,440 -2,583,699 -3,501,845 -10,784,708
Net Income/Loss Available To Common Stockholders, Basic -1,941,440 -2,583,699 -3,501,845 -10,784,708
Operating Expenses 2,057,639 2,687,265 3,552,556 10,921,736
Operating Income/Loss -1,941,433 -2,583,347 -3,501,897 -10,784,643
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 182,670 326,078 76,597 632,558
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2013-03-28
Assets UNPUB UNPUB UNPUB 6,826,133
Current Assets UNPUB UNPUB UNPUB 1,989,495
Current Liabilities UNPUB UNPUB UNPUB 1,650,598
Equity UNPUB UNPUB UNPUB 5,175,535
Equity Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Equity Attributable To Parent UNPUB UNPUB UNPUB 5,175,535
Liabilities UNPUB UNPUB UNPUB 1,650,598
Liabilities And Equity UNPUB UNPUB UNPUB 6,826,133
Noncurrent Assets UNPUB UNPUB UNPUB 4,836,638
Noncurrent Liabilities UNPUB UNPUB UNPUB 0
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2013-03-28
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow UNPUB UNPUB UNPUB -185,624
Net Cash Flow, Continuing UNPUB UNPUB UNPUB -185,624
Net Cash Flow From Financing Activities UNPUB UNPUB UNPUB 3,848,922
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB UNPUB 3,848,922
Net Cash Flow From Investing Activities UNPUB UNPUB UNPUB -134,582
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB UNPUB -134,582
Net Cash Flow From Operating Activities UNPUB UNPUB UNPUB -3,899,964
Net Cash Flow From Operating Activities, Continuing UNPUB UNPUB UNPUB -3,899,964
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2013-03-28
Comprehensive Income/Loss UNPUB UNPUB UNPUB -5,079,851
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB -5,079,851
Other Comprehensive Income/Loss UNPUB UNPUB UNPUB 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2013-03-28
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB 5,561,693
Cost Of Revenue UNPUB UNPUB UNPUB 35,745
Costs And Expenses UNPUB UNPUB UNPUB 5,561,693
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB 416,213
Income/Loss From Continuing Operations After Tax UNPUB UNPUB UNPUB -5,079,851
Income/Loss From Continuing Operations Before Tax UNPUB UNPUB UNPUB -5,079,851
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 0
Interest Expense, Operating UNPUB UNPUB UNPUB 12,040
Net Income/Loss UNPUB UNPUB UNPUB -5,079,851
Net Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Net Income/Loss Attributable To Parent UNPUB UNPUB UNPUB -5,079,851
Net Income/Loss Available To Common Stockholders, Basic UNPUB UNPUB UNPUB -5,079,851
Operating Expenses UNPUB UNPUB UNPUB 5,485,243
Operating Income/Loss UNPUB UNPUB UNPUB -5,069,030
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB UNPUB UNPUB 0
Preferred Stock Dividends And Other Adjustments UNPUB UNPUB UNPUB 0
Revenues UNPUB UNPUB UNPUB 481,842
Calendar
17 May 2024 (Time UTC) Actual Previous Consensus
★
15:30
United States
-17800.000
★
15:30
United States
-60000.000
★
15:30
United States
53700.000
★
15:30
United States
-135800.000
★★
15:30
United States
4400.000
★
15:30
United States
215400.000
★
15:30
United States
-31400.000
★
15:30
United States
62600.000
★
15:30
United States
1300.000
★
15:30
United States
-9700.000
★
15:30
United States
199600.000
★★
15:30
United States
★
15:30
United States
★
15:30
United States
★
15:30
United States
Options
Ticker
CFI
Contract Type
Exercise Style
Share Per Contract
Strike Price
Primary Exchange
Expiration Date
O:ATOS240517P00005000 OPASPS Put American 100 5 BATO 2024-05-17
O:ATOS240517P00004000 OPASPS Put American 100 4 BATO 2024-05-17
O:ATOS240517P00003000 OPASPS Put American 100 3 BATO 2024-05-17
O:ATOS240517P00002000 OPASPS Put American 100 2 BATO 2024-05-17
O:ATOS240517P00001000 OPASPS Put American 100 1 BATO 2024-05-17
O:ATOS240517C00005000 OCASPS Call American 100 5 BATO 2024-05-17
O:ATOS240517C00004000 OCASPS Call American 100 4 BATO 2024-05-17
O:ATOS240517C00003000 OCASPS Call American 100 3 BATO 2024-05-17
O:ATOS240517C00002000 OCASPS Call American 100 2 BATO 2024-05-17
O:ATOS240517C00001000 OCASPS Call American 100 1 BATO 2024-05-17
O:ATOS240419P00005000 OPASPS Put American 100 5 BATO 2024-04-19
O:ATOS240419C00005000 OCASPS Call American 100 5 BATO 2024-04-19
O:ATOS240419P00004000 OPASPS Put American 100 4 BATO 2024-04-19
O:ATOS240419P00003000 OPASPS Put American 100 3 BATO 2024-04-19
O:ATOS240419P00002000 OPASPS Put American 100 2 BATO 2024-04-19
O:ATOS240419P00001000 OPASPS Put American 100 1 BATO 2024-04-19
O:ATOS240419C00004000 OCASPS Call American 100 4 BATO 2024-04-19
O:ATOS240419C00003000 OCASPS Call American 100 3 BATO 2024-04-19
O:ATOS240419C00002000 OCASPS Call American 100 2 BATO 2024-04-19
O:ATOS240419C00001000 OCASPS Call American 100 1 BATO 2024-04-19
O:ATOS240315P00004000 OPASPS Put American 100 4 BATO 2024-03-15
O:ATOS240315P00003000 OPASPS Put American 100 3 BATO 2024-03-15
O:ATOS240315P00002000 OPASPS Put American 100 2 BATO 2024-03-15
O:ATOS240315P00001000 OPASPS Put American 100 1 BATO 2024-03-15
O:ATOS240315C00004000 OCASPS Call American 100 4 BATO 2024-03-15
O:ATOS240315C00003000 OCASPS Call American 100 3 BATO 2024-03-15
O:ATOS240315C00002000 OCASPS Call American 100 2 BATO 2024-03-15
O:ATOS240315C00001000 OCASPS Call American 100 1 BATO 2024-03-15
O:ATOS240216P00004000 OPASPS Put American 100 4 BATO 2024-02-16
O:ATOS240216P00003000 OPASPS Put American 100 3 BATO 2024-02-16
O:ATOS240216P00002000 OPASPS Put American 100 2 BATO 2024-02-16
O:ATOS240216P00001000 OPASPS Put American 100 1 BATO 2024-02-16
O:ATOS240216C00004000 OCASPS Call American 100 4 BATO 2024-02-16
O:ATOS240216C00003000 OCASPS Call American 100 3 BATO 2024-02-16
O:ATOS240216C00002000 OCASPS Call American 100 2 BATO 2024-02-16
O:ATOS240216C00001000 OCASPS Call American 100 1 BATO 2024-02-16
O:ATOS240119P00007000 OPASPS Put American 100 7 BATO 2024-01-19
O:ATOS240119P00005000 OPASPS Put American 100 5 BATO 2024-01-19
O:ATOS240119P00004000 OPASPS Put American 100 4 BATO 2024-01-19
O:ATOS240119P00003000 OPASPS Put American 100 3 BATO 2024-01-19
O:ATOS240119P00002500 OPASPS Put American 100 2.5 BATO 2024-01-19
O:ATOS240119P00002000 OPASPS Put American 100 2 BATO 2024-01-19
O:ATOS240119P00001500 OPASPS Put American 100 1.5 BATO 2024-01-19
O:ATOS240119P00001000 OPASPS Put American 100 1 BATO 2024-01-19
O:ATOS240119P00000500 OPASPS Put American 100 0.5 BATO 2024-01-19
O:ATOS240119C00007000 OCASPS Call American 100 7 BATO 2024-01-19
O:ATOS240119C00005000 OCASPS Call American 100 5 BATO 2024-01-19
O:ATOS240119C00004000 OCASPS Call American 100 4 BATO 2024-01-19
O:ATOS240119C00003000 OCASPS Call American 100 3 BATO 2024-01-19
O:ATOS240119C00002500 OCASPS Call American 100 2.5 BATO 2024-01-19
O:ATOS240119C00002000 OCASPS Call American 100 2 BATO 2024-01-19
O:ATOS240119C00001500 OCASPS Call American 100 1.5 BATO 2024-01-19
O:ATOS240119C00001000 OCASPS Call American 100 1 BATO 2024-01-19
O:ATOS240119C00000500 OCASPS Call American 100 0.5 BATO 2024-01-19
O:ATOS231215P00004000 OPASPS Put American 100 4 BATO 2023-12-15
O:ATOS231215P00003000 OPASPS Put American 100 3 BATO 2023-12-15
O:ATOS231215P00002000 OPASPS Put American 100 2 BATO 2023-12-15
O:ATOS231215P00001000 OPASPS Put American 100 1 BATO 2023-12-15
O:ATOS231215C00004000 OCASPS Call American 100 4 BATO 2023-12-15
O:ATOS231215C00003000 OCASPS Call American 100 3 BATO 2023-12-15
O:ATOS231215C00002000 OCASPS Call American 100 2 BATO 2023-12-15
O:ATOS231215C00001000 OCASPS Call American 100 1 BATO 2023-12-15
O:ATOS231117P00004000 OPASPS Put American 100 4 BATO 2023-11-17
O:ATOS231117P00003000 OPASPS Put American 100 3 BATO 2023-11-17
O:ATOS231117P00002000 OPASPS Put American 100 2 BATO 2023-11-17
O:ATOS231117P00001000 OPASPS Put American 100 1 BATO 2023-11-17
O:ATOS231117C00004000 OCASPS Call American 100 4 BATO 2023-11-17
O:ATOS231117C00003000 OCASPS Call American 100 3 BATO 2023-11-17
O:ATOS231117C00002000 OCASPS Call American 100 2 BATO 2023-11-17
O:ATOS231117C00001000 OCASPS Call American 100 1 BATO 2023-11-17
O:ATOS231020P00004000 OPASPS Put American 100 4 BATO 2023-10-20
O:ATOS231020P00003000 OPASPS Put American 100 3 BATO 2023-10-20
O:ATOS231020P00002000 OPASPS Put American 100 2 BATO 2023-10-20
O:ATOS231020P00001000 OPASPS Put American 100 1 BATO 2023-10-20
O:ATOS231020C00004000 OCASPS Call American 100 4 BATO 2023-10-20
O:ATOS231020C00003000 OCASPS Call American 100 3 BATO 2023-10-20
O:ATOS231020C00002000 OCASPS Call American 100 2 BATO 2023-10-20
O:ATOS231020C00001000 OCASPS Call American 100 1 BATO 2023-10-20
O:ATOS230915P00004000 OPASPS Put American 100 4 BATO 2023-09-15
O:ATOS230915P00003000 OPASPS Put American 100 3 BATO 2023-09-15
O:ATOS230915P00002000 OPASPS Put American 100 2 BATO 2023-09-15
O:ATOS230915P00001000 OPASPS Put American 100 1 BATO 2023-09-15
O:ATOS230915C00004000 OCASPS Call American 100 4 BATO 2023-09-15
O:ATOS230915C00003000 OCASPS Call American 100 3 BATO 2023-09-15
O:ATOS230915C00002000 OCASPS Call American 100 2 BATO 2023-09-15
O:ATOS230915C00001000 OCASPS Call American 100 1 BATO 2023-09-15
O:ATOS230818P00004000 OPASPS Put American 100 4 BATO 2023-08-18
O:ATOS230818P00003000 OPASPS Put American 100 3 BATO 2023-08-18
O:ATOS230818P00002000 OPASPS Put American 100 2 BATO 2023-08-18
O:ATOS230818P00001000 OPASPS Put American 100 1 BATO 2023-08-18
O:ATOS230818C00004000 OCASPS Call American 100 4 BATO 2023-08-18
O:ATOS230818C00003000 OCASPS Call American 100 3 BATO 2023-08-18
O:ATOS230818C00002000 OCASPS Call American 100 2 BATO 2023-08-18
O:ATOS230818C00001000 OCASPS Call American 100 1 BATO 2023-08-18
News Stream
Health Health
Atossa Therapeutics Announces Last Patient, Last Dose in its Phase 2 Karisma-Endoxifen Clinical Trial
SEATTLE, May 15, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced that the last patient in the Company’s Karisma-Endoxifen clinical trial received their final dose of study medication. Atossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer.
GlobeNewswire Inc. • 4d ago
Stocks Earnings Releases and Operating Results
Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
SEATTLE, May 13, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced financial results for the fiscal quarter ended March 31, 2024, and provides an update on recent company developments. Atossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer
GlobeNewswire Inc. • 6d ago
News Product / Services Announcement
Atossa Therapeutics Announces Support of New Breast Cancer Screening Guidelines
SEATTLE, May 07, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced its support of new guidelines released by the U.S. Preventive Services Task Force (USPSTF) recommending that women begin breast cancer screening starting at age 40. Atossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer.
GlobeNewswire Inc. • 1w ago
Stocks Business Contracts
Atossa Therapeutics Announces Expanded Research Agreement with Weill Cornell Medicine to Further Evaluate Synergy Between Antibody Drug Conjugates (ADCs) and (Z)-Endoxifen
SEATTLE, April 29, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced an expanded research agreement with Weill Cornell Medicine to explore the potential synergy between antibody drug conjugates (ADCs) and (Z)-endoxifen. Atossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer.
GlobeNewswire Inc. • 2w ago
Calendar Calendar of Events
Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare Conference
SEATTLE, April 11, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced that Chief Executive Officer Steven Quay, M.D., Ph.D., will speak at the Noble Capital Markets Emerging Growth Healthcare Conference on Wednesday, April 17 at 9:00 am ET. The presentation will be available virtually and members of the Company’s leadership team will be available for one-on-one meetings with registered investors of the conference. Atossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer.
GlobeNewswire Inc. • 1mo ago
Stocks Company Announcement
Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100% Disease Control Rate After 24-Weeks of Treatment with (Z)-Endoxifen
SEATTLE, April 09, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced promising safety and efficacy data from the Company’s Phase 2 EVANGELINE (Endoxifen Versus exemestANe GosEreLIn) clinical trial. The EVANGELINE study is evaluating (Z)-endoxifen as a neoadjuvant treatment for pre-menopausal women with Grade 1 or 2 Estrogen Receptor positive (ER+) / Human Epidermal Growth Factor Receptor 2 negative (HER2-) breast cancer. Atossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer.
GlobeNewswire Inc. • 1mo ago
Stocks Earnings Releases and Operating Results
Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update
SEATTLE, April 01, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced financial results for the fourth quarter and full year ended December 31, 2023, and provided an update on recent Company developments. Atossa is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer and other breast conditions.
GlobeNewswire Inc. • 1mo ago
Health Health
Atossa Therapeutics Provides Five-Year (Z)-Endoxifen Treatment Update on FDA-Approved "Expanded Access" Program for a U.S. Breast Cancer Patient
SEATTLE, March 19, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced that the pre-menopausal, Estrogen Receptor positive (ER+) / Human Epidermal Growth Factor Receptor 2 negative (HER2-), breast cancer patient who received neoadjuvant and adjuvant (Z)-endoxifen therapy under an FDA-approved "expanded access" program has completed five years of treatment. As of the date of this press release, the patient remains cancer-free and has reported no significant safety or tolerability issues over the course of her treatment. Atossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer.
GlobeNewswire Inc. • 2mo ago
Stocks Major shareholder announcements
Atossa Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirements
SEATTLE, March 18, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced that on March 15, 2024, the Company received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with the minimum closing bid price requirement under Nasdaq Listing Rule 5550(a)(2). Atossa is a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology, with a focus on using (Z)-endoxifen to prevent and treat breast cancer.
GlobeNewswire Inc. • 2mo ago
Management Directors and Officers
Atossa Therapeutics Appoints Breast Cancer Specialist Tessa Cigler, M.D., M.P.H. to its Board of Directors
SEATTLE, March 12, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer, today announced that Tessa Cigler, M.D., M.P.H. was appointed to Atossa’s board of directors, effective immediately. Dr. Cigler is a medical oncologist and clinical investigator at the Weill Cornell Breast Center in New York City.
GlobeNewswire Inc. • 2mo ago
See All
Related
Latest

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT